Latest news and press releases about HeartSciences Inc. (HSCS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process.
Price
| Price | $3.79 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 53.02 |
| EV / EBITDA | 195.51 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -358.44% |
| Return on Invested Capital | -202.10% |
| Return on Assets | -173.71% |
| Gross Margin | -2982.10% |
| Operating Margin | -194787.38% |
| Net Margin | -211666.47% |
Related companies: AMIX · BCLI · BMRA · GBS · IBO · MTNB · MYNZ
Explore sector: Healthcare · Medical - Devices
More sections of HSCS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks